Age | 1.06 (1.03–1.10) | <0.001 | 1.09 (1.03–1.14) | 0.001 |
MI (all degrees) | 2.94 (1.30–6.67) | 0.010 | 5.45 (1.84–16.2) | 0.002 |
Hypertension | 3.12 (1.37–7.10) | 0.007 | 2.81 (1.03–7.62) | 0.043 |
CRP (mg/l) (after 2 weeks) | 1.01 (1.00–1.03) | 0.040 | 1.00 (0.99–1.01) | 0.75 |
Creatinine (μmol/l) | 1.02 (1.00–1.02) | 0.006 | 1.02 (1.00–1.04) | 0.025 |
GFR (MDRD) | 0.98 (0.97–1.00) | 0.012 | 0.98 (0.96–1.00) | 0.041 |
logNT-proBNP (ng/l) (at admission) | 12.2 (4.28–34.9) | <0.001 | 23.2 (4.68–115.0) | <0.001 |
logNT-proBNP (ng/l) (after 2 weeks) | 5.91 (2.43–14.4) | <0.001 | 9.44 (2.83–31.5) | <0.001 |
CysC (mg/l) (at admission) | 7.11 (2.59–19.5) | <0.001 | 37.5 (4.58–308.1) | 0.001 |
CysC (mg/l) (after 2 weeks) | 2.55 (1.37–4.76) | 0.003 | 41.7 (5.43–320.6) | <0.001 |
CysC (mg/l) (>20% increase) | 2.82 (1.20–6.59) | 0.017 | 2.60 (0.90–7.50) | 0.080 |
TnT (ng/l) (after 2 weeks) | 1.00 (1.00–1.01) | 0.059 | 1.03 (1.01–1.05) | 0.008 |
IL-6 (ng/l) (after 2 weeks) | 1.02 (1.00–1.03) | 0.044 | 1.10 (1.04–1.17) | 0.002 |